• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项利用γ闪烁显像技术对用于回结肠给药的pH响应性聚合物在人体中的体内性能变异性进行的研究。

An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans.

作者信息

Ibekwe Valentine C, Liu Fang, Fadda Hala M, Khela Mandeep K, Evans David F, Parsons Gary E, Basit Abdul W

机构信息

Department of Pharmaceutics, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, UK.

出版信息

J Pharm Sci. 2006 Dec;95(12):2760-6. doi: 10.1002/jps.20742.

DOI:10.1002/jps.20742
PMID:16917845
Abstract

Gastrointestinal performance of tablets coated with pH responsive acrylic polymers (Eudragit) was investigated in human volunteers. Tablet cores were coated with Eudragit S dissolved in ethanol (organic), Eudragit S aqueous dispersion (aqueous), or Eudragit FS aqueous dispersion. Eight fasted volunteers received the tablets in a two-way crossover design-treatment 1: Eudragit S (organic) and Eudragit FS coated tablets; treatment 2: Eudragit S (aqueous) and Eudragit FS coated tablets. Eudragit FS coated tablets were included in both treatments to assess its intra-subject performance. Tablets were radiolabelled and followed by gamma scintigraphy; the disintegration times and positions were recorded. Tablets coated with Eudragit S (aqueous) disintegrated in all volunteers mainly in the proximal to mid small intestine. Eudragit S (organic) tablets failed to disintegrate in three out of eight volunteers, while disintegration was in the ileo-caecal junction and ascending colon in all others. Eudragit FS coated tablets disintegrated in 14 out of the 16 administrations. The Eudragit FS coated tablets that did disintegrate exhibited consistent intra- and inter-subject performance, with the site of disintegration focused on the ileo-caecal junction and ascending colon. These in vivo results correlate better with our published in vitro dissolution data in physiological bicarbonate buffers compared to phosphate buffers.

摘要

在人类志愿者中研究了用pH响应性丙烯酸聚合物(尤特奇)包衣的片剂的胃肠道性能。片剂芯用溶解在乙醇中的尤特奇S(有机型)、尤特奇S水分散体(水性型)或尤特奇FS水分散体包衣。八名空腹志愿者以两交叉设计接受片剂——治疗1:尤特奇S(有机型)和尤特奇FS包衣片剂;治疗2:尤特奇S(水性型)和尤特奇FS包衣片剂。两种治疗中均包含尤特奇FS包衣片剂以评估其个体内性能。片剂用放射性标记并通过γ闪烁扫描法跟踪;记录崩解时间和位置。用尤特奇S(水性型)包衣的片剂在所有志愿者中主要在小肠近端至中部崩解。尤特奇S(有机型)片剂在八名志愿者中有三名未崩解,而其他所有志愿者的片剂在回盲部和升结肠崩解。尤特奇FS包衣片剂在16次给药中有14次崩解。已崩解的尤特奇FS包衣片剂在个体内和个体间表现出一致的性能,崩解部位集中在回盲部和升结肠。与磷酸盐缓冲液相比,这些体内结果与我们发表的在生理碳酸氢盐缓冲液中的体外溶出数据相关性更好。

相似文献

1
An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans.一项利用γ闪烁显像技术对用于回结肠给药的pH响应性聚合物在人体中的体内性能变异性进行的研究。
J Pharm Sci. 2006 Dec;95(12):2760-6. doi: 10.1002/jps.20742.
2
A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.一种新型的回肠结肠药物靶向涂层概念:应用闪烁成像术在人体中进行概念验证。
Eur J Pharm Biopharm. 2013 Aug;84(3):573-7. doi: 10.1016/j.ejpb.2013.01.002. Epub 2013 Jan 21.
3
A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.用于回肠-结肠给药的pH响应性聚合物药物释放性能的体外比较评估。
Int J Pharm. 2006 Feb 3;308(1-2):52-60. doi: 10.1016/j.ijpharm.2005.10.038. Epub 2005 Dec 13.
4
A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.一种新型双层包衣方法,可改善对胃肠道回肠结肠区域的 pH 触发递药。
Eur J Pharm Biopharm. 2010 Feb;74(2):311-5. doi: 10.1016/j.ejpb.2009.11.008. Epub 2009 Nov 20.
5
Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.肠道pH值、转运时间和进食状态对pH响应型回肠-结肠释放系统体内性能的相互作用。
Pharm Res. 2008 Aug;25(8):1828-35. doi: 10.1007/s11095-008-9580-9. Epub 2008 May 9.
6
Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.加速肠溶衣在小肠上段的溶解:一种用于评估药物释放的新型pH 5.6碳酸氢盐缓冲系统的演变
Int J Pharm. 2014 Jul 1;468(1-2):172-7. doi: 10.1016/j.ijpharm.2014.04.019. Epub 2014 Apr 13.
7
A paradigm shift in enteric coating: achieving rapid release in the proximal small intestine of man.肠溶性包衣的范式转变:实现人体近端小肠的快速释放。
J Control Release. 2010 Oct 15;147(2):242-5. doi: 10.1016/j.jconrel.2010.07.105. Epub 2010 Jul 22.
8
Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.新型pH敏感聚合物P-4135F包衣片的诺氟沙星释放特性研究
J Drug Target. 1999;7(3):223-32. doi: 10.3109/10611869909085505.
9
Enteric coated HPMC capsules designed to achieve intestinal targeting.肠溶包衣的羟丙基甲基纤维素胶囊旨在实现肠道靶向。
Int J Pharm. 2002 Jan 1;231(1):83-95. doi: 10.1016/s0378-5173(01)00871-7.
10
A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.一种使用甲基丙烯酸共聚物的pH依赖性结肠靶向口服给药系统。I. 使用尤特奇L100-55和尤特奇S100组合控制药物释放
J Control Release. 1999 Mar 29;58(2):215-22. doi: 10.1016/s0168-3659(98)00151-5.

引用本文的文献

1
Advancing Inflammatory Bowel Disease Treatment by Targeting the Innate Immune System and Precision Drug Delivery.通过靶向先天免疫系统和精准药物递送推进炎症性肠病治疗
Int J Mol Sci. 2025 Jan 11;26(2):575. doi: 10.3390/ijms26020575.
2
Advances in colon-targeted drug technologies.结肠靶向给药技术的进展。
Curr Opin Gastroenterol. 2025 Jan 1;41(1):9-15. doi: 10.1097/MOG.0000000000001064. Epub 2024 Oct 11.
3
Quality by Design (QbD) Approach to Develop Colon-Specific Ketoprofen Hot-Melt Extruded Pellets: Impact of Eudragit S 100 Coating on the In Vitro Drug Release.
采用质量源于设计(QbD)方法研发结肠靶向酮洛芬热熔挤出微丸:Eudragit S 100包衣对体外药物释放的影响
Pharmaceutics. 2024 Sep 27;16(10):1265. doi: 10.3390/pharmaceutics16101265.
4
Enteric-Coated Capsules Providing Reliable Site-Specific Drug Delivery to the Distal Ileum.肠溶胶囊可将药物靶向递送至回肠末端,确保可靠的定位释药。
Mol Pharm. 2024 Jun 3;21(6):2828-2837. doi: 10.1021/acs.molpharmaceut.3c01241. Epub 2024 May 9.
5
Silk Fibroin-Based Coatings for Pancreatin-Dependent Drug Delivery.基于丝素蛋白的涂层用于胰酶依赖性药物递送。
J Pharm Sci. 2024 Mar;113(3):718-724. doi: 10.1016/j.xphs.2023.09.001. Epub 2023 Sep 9.
6
In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications.用于评估结肠靶向药物产品的体外方法及其应用的行业观点。
Pharmaceutics. 2022 Jan 26;14(2):291. doi: 10.3390/pharmaceutics14020291.
7
Controlled Delivery of Bile Acids to the Colon.胆汁酸结肠递药系统
Clin Transl Gastroenterol. 2020 Dec;11(12):e00229. doi: 10.14309/ctg.0000000000000229.
8
Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements.结肠靶向给药的策略方法:近期进展概述
Pharmaceutics. 2020 Jan 15;12(1):68. doi: 10.3390/pharmaceutics12010068.
9
Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder.HLD200(一种缓释和长效释放的哌甲酯制剂)在健康成人以及患有注意力缺陷/多动障碍的青少年和儿童中的单剂量药代动力学。
J Child Adolesc Psychopharmacol. 2018 Feb;28(1):10-18. doi: 10.1089/cap.2017.0044. Epub 2017 Oct 17.
10
Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of Naproxen for chronotherapeutic treatment of rheumatoid arthritis.用于类风湿性关节炎时辰治疗的萘普生回肠结肠靶向基质迷你片的制剂与评价
Saudi Pharm J. 2016 Jan;24(1):64-73. doi: 10.1016/j.jsps.2015.03.001. Epub 2015 Mar 20.